clinical trials - Erythromelalgia Warriors: Patient Support & Information Network

clinical trials (1)

New drug for erythromelalgia goes into Phase 2 (2017)

ERYTHROMELALGIA NEWS!

Convergence Pharmaceuticals have announced their phase 2a study of BIIB-074 in the treatment of erythromelalgia (Enrollment by invitation only) A Phase 2a Study of BIIB-074 in the Treatment of Erythromelalgia

#xg { position:relative;top:120px; } #xn_bar { top:120px; }

Hello, you need to enable JavaScript to use Erythromelalgia Warriors: Patient Support & Information Network.

Please check your browser settings or contact your system administrator.